# The Dragon PLC Trial (DRAGON-PLC)

> **NCT06914648** · NA · RECRUITING · sponsor: **Maastricht University** · enrollment: 358 (estimated)

## Conditions studied

- Primary Liver Cancer
- Hepatocellular Carcinoma (HCC)
- Cholangiocarcinoma

## Interventions

- **PROCEDURE:** Portal Vein Embolization
- **PROCEDURE:** Hepatic Vein Embolization

## Key facts

- **NCT ID:** NCT06914648
- **Lead sponsor:** Maastricht University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2032-11-15
- **Final completion:** 2032-11-15
- **Target enrollment:** 358 (ESTIMATED)
- **Last updated:** 2025-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06914648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06914648, "The Dragon PLC Trial (DRAGON-PLC)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06914648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*